Inflammatory myofibroblastic tumour pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2017.

Inflammatory myofibroblastic tumour (IMT) rarely presents in the skin as a slow-growing dermal tumour. Many tumours show a translocation of the ALK gene. Some of these tumours were labelled "pseudotumours" or "plasma cell granuloma" in the past.

Histology of inflammatory myofibroblastic tumour

Histologically, the lesion is based in the dermis and seen underlying a normal epidermis (figure 1). The tumour is composed of an admixture of spindle-shaped and ovoid cells with a prominent inflammatory infiltrate (figures 2-4). The infiltrate is characteristically rich in plasma cells (best seen in figure 3). There may be some pleomorphism of the tumour cells and some mitotic figures (figure 4, arrow).

Special stains for inflammatory myofibroblastic tumour

The tumour cells stain strongly with vimentin and variably with smooth muscle markers. SMA is positive in up to 90% of cases. ALK (anaplastic lymphoma kinase) immunohistochemistry is seen in the majority of cases and when seen is practically diagnostic in the correct context. FISH testing for ALK-gene rearrangements may also be used.

Differential diagnosis of inflammatory myofibroblastic tumour pathology

Various inflammatory mesenchymal tumours - Pleomorphic sarcomas melanoma, and leiomyosarcoma have inflammatory variants. ALK positivity by immunohistochemistry of FISH can be helpful in difficult cases. 

Pseudotumour and plasma cell granuloma - These lack significant atypia and ALK gene translocations. Many IMTs were labelled pseudotumours in the past.

Related information

Email Newsletter

Would you like to receive DermNet updates by email?

Submit your images

We're seeking high-quality photos of skin diseases.  


Skin lesion photography

Watch Dr Amanda Oakley presenting "Skin lesion photography" at The Australasian Skin Cancer Congress.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter